Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells.

Viale A, De Franco F, Orleth A, Cambiaghi V, Giuliani V, Bossi D, Ronchini C, Ronzoni S, Muradore I, Monestiroli S, Gobbi A, Alcalay M, Minucci S, Pelicci PG.

Nature. 2009 Jan 1;457(7225):51-6. doi: 10.1038/nature07618.

PMID:
19122635
2.

Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway.

Insinga A, Monestiroli S, Ronzoni S, Gelmetti V, Marchesi F, Viale A, Altucci L, Nervi C, Minucci S, Pelicci PG.

Nat Med. 2005 Jan;11(1):71-6. Epub 2004 Dec 26. Erratum in: Nat Med. 2005 Feb;11(2):233.

3.

Impairment of p53 acetylation, stability and function by an oncogenic transcription factor.

Insinga A, Monestiroli S, Ronzoni S, Carbone R, Pearson M, Pruneri G, Viale G, Appella E, Pelicci P, Minucci S.

EMBO J. 2004 Mar 10;23(5):1144-54. Epub 2004 Feb 19.

4.

Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells.

Bertolini F, Paul S, Mancuso P, Monestiroli S, Gobbi A, Shaked Y, Kerbel RS.

Cancer Res. 2003 Aug 1;63(15):4342-6.

5.

Eosinophilic crystals as a distinctive morphologic feature of a hyaline droplet nephropathy in a mouse model of acute myelogenous leukaemia.

Marchesi F, Monestiroli SV, Capillo M, Gobbi A, Minucci S, Pelicci PG, Scanziani E.

J Vet Med A Physiol Pathol Clin Med. 2003 Mar;50(2):103-7.

PMID:
12667201
6.

Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors.

Capillo M, Mancuso P, Gobbi A, Monestiroli S, Pruneri G, Dell'Agnola C, Martinelli G, Shultz L, Bertolini F.

Clin Cancer Res. 2003 Jan;9(1):377-82.

7.

PML-RAR induces promyelocytic leukemias with high efficiency following retroviral gene transfer into purified murine hematopoietic progenitors.

Minucci S, Monestiroli S, Giavara S, Ronzoni S, Marchesi F, Insinga A, Diverio D, Gasparini P, Capillo M, Colombo E, Matteucci C, Contegno F, Lo-Coco F, Scanziani E, Gobbi A, Pelicci PG.

Blood. 2002 Oct 15;100(8):2989-95.

PMID:
12351412
8.

CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma.

Bertolini F, Dell'Agnola C, Mancuso P, Rabascio C, Burlini A, Monestiroli S, Gobbi A, Pruneri G, Martinelli G.

Cancer Res. 2002 Jun 1;62(11):3106-12.

9.

Cilia-Associated Respiratory (CAR) bacillus infection in veal calves and adult cattle.

Pravettoni D, Toccacieli S, Monestiroli S, Crippa L, Canali E, Salvi S, Scanziani E.

Dtsch Tierarztl Wochenschr. 2001 Sep;108(9):386-9.

PMID:
11599441
10.

Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma.

Monestiroli S, Mancuso P, Burlini A, Pruneri G, Dell'Agnola C, Gobbi A, Martinelli G, Bertolini F.

Cancer Res. 2001 Jun 1;61(11):4341-4.

11.

Histological and immunohistochemical detection of different Helicobacter species in the gastric mucosa of cats.

Scanziani E, Simpson KW, Monestiroli S, Soldati S, Strauss-Ayali D, Del Piero F.

J Vet Diagn Invest. 2001 Jan;13(1):3-12.

PMID:
11243359
12.

Activation of the orphan nuclear receptor RORalpha induces growth arrest in androgen-independent DU 145 prostate cancer cells.

Moretti RM, Marelli MM, Motta M, Polizzi D, Monestiroli S, Pratesi G, Limonta P.

Prostate. 2001 Mar 1;46(4):327-35.

13.

Preclinical evaluation of new anthracyclines.

Pratesi G, Monestiroli SV.

Curr Med Chem. 2001 Jan;8(1):9-13. Review.

PMID:
11172688
14.

Oral efficacy and bioavailability of a novel taxane.

Polizzi D, Pratesi G, Monestiroli S, Tortoreto M, Zunino F, Bombardelli E, Riva A, Morazzoni P, Colombo T, D'Incalci M, Zucchetti M.

Clin Cancer Res. 2000 May;6(5):2070-4.

Supplemental Content

Loading ...
Support Center